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Abstract The temporal sequence of PTH/PTHrP receptor mRNA, binding, biologic activity, and i t s  dependence 
on matrix synthesis was determined using MC3T3-El preosteoblast-like cells and primary rat calvarial cells in vitro. 
Osteoblastic cells were induced to differentiate and form mineralized nodules with the addition of ascorbic acid and 
p-glycerophosphate, and samples were collected from 0-26 days of culture. DNA levels as determined by fluorometric 
analysis increased 12- and 17-fold during the collection period for both MC3T3-EI and primary calvarial cells 
respectively. Steady state mRNA levels for the PTH/PTHrP receptor as determined by northern blot analysis, were 
initially low for both cell types, peaked at day 4 and 5 for MC3T3-El and primary calvarial cells respectively, and 
declined thereafter. Competition binding curves were performed during differentiation using 1251-PTHrP. The numbers 
of receptors per pg DNA were greatest at days 3 and 5 for MC3T3-El and primary calvarial cells respectively. The 
biologic activity of the receptor was evaluated by stimulating the cells with 10 nM PTHrP and determining cAMP levels 
via a binding protein assay. The PTHrP-stimulated cAMP levels increased 5-fold to peak values at day 5 for MC3T3-EI 
cells and 6-fold to peak values at day 4 for the primary calvarial cells. Ascorbic acid was required for maximal 
development of a PTH-dependent cAMP response since ascorbic acid-treated MC3T3-EI cells had twice the PTH- 
stimulated cAMP levels as non-treated cells. When the collagen synthesis inhibitor 3,4-dehydroproline was adminis- 
tered to MC3T3-EI cultures prior to differentiation, there was a subsequent diminution of the PTH/PTHrP receptor 
mRNA gene expression and numbers of receptors per cell; however, if administered after the initiation of matrix 
synthesis there was no reduction in PTH/PTHrP receptor mRNA. These findings indicate that the PTH/ PTHrP receptor is 
associated temporally at the level of mRNA, protein, and biologic activity, with a differentiating, matrix-producing 
osteoblastic cell in vitro. 
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Parathyroid hormone (PTH) is a major regu- 
lator of systemic calcium metabolism at least in 
part via its interaction with cell surface recep- 
tors on osteoblastic cells [Juppner et al., 19911. 
PTH-related protein (PTHrP) is an autocrine or 
paracrine factor that binds to the same receptor 
on osteoblastic cells. PTH and PTHrP have been 
found to have both anabolic and catabolic effects 
in bone; although the mechanisms of action of 
these two diverse effects are not known. Osteo- 
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blasts progress through a well characterized pat- 
tern of proliferation and differentiation and are 
responsible for forming the mineralized matrix 
of bone [Lian and Stein, 19921. Knowledge of 
the specific stages during differentiation in which 
the osteoblast is responsive to PTH and PTHrP 
is critical to determine the precise mechanisms 
of anabolic and catabolic effects of PTH and 
PTHrP in bone. 
Numerous studies have characterized the os- 
teoblast phenotype during cultivation of cells 
and production of a mineralized matrix in vitro 
[Malaval et al., 1994; Franceschi and Iyer, 1992; 
Tenenbaum and Heersche, 19821. One of the 
characteristics often used to classify osteoblastic 
cells is the presence of PTH/PTHrP receptors or 
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biologic response to PTH in vitro [Wong, 19901. 
Several studies suggest that the presence of the 
PTH/PTHrP receptor is associated with a spe- 
cific stage of differentiation; however, there are 
no reports correlating the expression of the PTHI 
PTHrP receptor at the mRNA, ligand binding, 
and biologic activity levels. An in vivo autoradio- 
graphic study reported that PTH binding was 
localized over cells described as immature stro- 
ma1 cells [Rouleau et al., 19881. In contrast, 
PTH/PTHrP receptor mRNA levels were great- 
est in active osteoblasts lining trabecular bone 
as demonstrated by in situ hybridization [Lee et 
al., 19941. In vitro, it has been suggested that 
the PTH/PTHrP receptor is associated with a 
mature, cuboidal cell, and that it is expressed as 
osteoblastic cells differentiate Pamarnoto et al., 
1988; Turksen and Aubin, 19911; however, de- 
tailed analysis is lacking. 
Expression of other osteoblast marker pro- 
teins such as alkaline phosphatase and osteocal- 
cin requires growth of cells in ascorbic acid- 
containing medium [Franceschi and Iyer, 19921. 
We recently reported that the ascorbic acid re- 
quirement is related to the ability of this vita- 
min to  stimulate collagen matrix formation since 
incorporation of proline analogues into procolla- 
gen that disrupt the triple-helical structure of 
this molecule prevented the induction of osteo- 
blast marker protein genes [Franceschi and Iyer, 
1992; Franceschi et al., 19941. It is not known if 
expression of the PTH/PTHrP receptor simi- 
larly requires collagen matrix synthesis. 
The objectives of the present study were to 
determine the temporal sequence of expression 
and activity of the PTH/PTHrP receptor during 
osteoblastic differentiation in vitro and to re- 
solve whether receptor expression requires the 
synthesis of a collagenous matrix. These studies 
provide insight into the character of cells which 
respond to PTH or PTHrP and may be impor- 
tant in designing treatment strategies for target- 
ing anabolic actions of PTH in bone. 
MATERIALS AND METHODS 
Cell Culture 
MC3T3-El cells were obtained from Dr. M. 
Kumegawa (Meikai University, Sakado, Japan) 
and maintained as previously described [Fran- 
ceschi and Iyer, 19921. Briefly, stock cultures 
were grown in a-modified Eagle’s medium (a- 
MEM) (JRH Biosciences) and 10% fetal bovine 
serum containing 100 units/ml of penicillin and 
streptomycin. Cells were passaged every 4-5 
days and were not used beyond passage 15. 
MC3T3-El cells were plated at  initial densities 
of 10,000/cm2 except in studies that examined 
the requirement for ascorbic acid and collagen 
synthesis on receptor expression where cells were 
plated at  an initial density of 50,00O/cm? 
Primary rat calvarial cells were isolated accord- 
ing to published techniques [Pockwinse et al., 
19921. Briefly, calvaria of fetal rats of 21 days 
gestation were dissected, isolated from perios- 
teum, and subjected to sequential digestions of 
20, 40, and 90 min in collagenase A (2 mg/ml, 
Boehringer-Mannheim, Indianapolis, IN) with 
0.25% trypsin (Gibco BRL, Grand Island, NY). 
Cells from the third digest were washed, counted, 
and plated in a-MEM with 10% fetal bovine 
serum containing 100 units/ml of penicillin and 
streptomycin, at a density of 20,000/cm2. Pri- 
mary cultures were used without passage. 
Cells were plated in either 35 mm (CAMP 
assays), 60 mm tissue culture dishes (RNA isola- 
tion), or 24-well plates (receptor binding assays) 
at an initial density of 10,000 or 20,000 cells/ 
cm2. After 24 h (MC3T3-El cells) or 4 days 
(primary calvarial cells), medium was changed 
to a-MEM with 10% fetal bovine serum supple- 
mented with 50 kg/ml of ascorbic acid (Sigma) 
and 10 mM P-glycerophosphate (Sigma) to  in- 
duce osteoblastic differentiation and mineraliza- 
tion in vitro. The concentration of ascorbic acid 
used in these experiments optimally stimulates 
differentiation of MC3T3-E 1 cells [Franceschi 
and Iyer, 19921 and saturates a recently de- 
scribed plasma membrane-associated ascorbate 
transporter [Franceschi et al., 19951. 
Northern Blot Analysis 
RNA was isolated and northern blot analysis 
performed as described [McCauley et al., 19941. 
Briefly, total RNA was isolated from one 60 mm 
dish by the guanidinium isothiocyanate method 
[Chomczynski and Sacchi, 19871 and quanti- 
tated by spectrophotometry. Total RNA (20 kg) 
was electrophoresed on 1.2% agarose-formalde- 
hyde gels. The RNA was transferred to  nylon 
membranes (Duralon U.V., Stratagene Inc. La 
Jolla, CA) and U.V. crosslinked. The nylon mem- 
branes were hybridized with a cDNA probe 
(R15B) encoding the rat PTH/PTHrP receptor 
[Abou-Samra et al., 19921. After hybridization 
and washing, blots were exposed to Kodak X- 
OMAT film at -70°C for 24-72 h. Blots were 
also stripped and reprobed with a cDNA probe 
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for 18s rRNA [Renkawitz and Gerbi, 19791, to 
control for RNA loading. 
Autoradiographs were evaluated for relative 
signal density with NIH Image Software and 
data expressed as a ratio of signal density for 
PTH/PTHrP receptor vs. 18s rRNA. 
Receptor Binding Assays 
PTH/PTHrP receptor binding assays were 
performed as described [McCauley et al., 1992al. 
Briefly, cells were plated in 24-well plates and 
binding assays performed at the indicated times 
after the introduction of ascorbic acid and P-glyc- 
erophosphate to culture media. Triplicate wells 
were incubated with 20,000 cpm of high perfor- 
mance liquid chromotography-purified monoio- 
dinated-1251-[Tyr36]-hPTHrP (1-36) amide [Mc- 
Cauley et al., 1992b1, in addition to varying 
concentrations of nonradioactive hPTHrP (1- 
34) amide (Bachem Inc., Torrance, CA). The 
cells were incubated for 2 h at 4°C with gentle 
shaking. The unbound peptides were washed 
twice from the cell monolayer with Hank’s buff- 
ered salt solution (HBSS), the cells were lysed 
with 0.5 M NaOH for 30 min, and the resultant 
suspension counted in a scintillation counter. 
Three wells from each plate were utilized to 
determine DNA levels as described using fluori- 
metric analysis [McCauley et al., 19951. 
Adenylate Cyclase Stimulation Assay 
The adenylate cyclase stimulation assay and 
CAMP binding assay were performed as previ- 
ously described [McCauley et al., 1992133. Briefly, 
for each time point, six 35 mm dishes of 
MC3T3-El or primary rat calvarial cells were 
evaluated. Three plates were stimulated with 10 
nM hPTHrP (1-34) amide, hPTH (1-34) amide 
(Bachem Inc.), or vehicle control as indicated for 
10 min at 37°C in calcium- and magnesium-free 
HBSS containing 0.1% bovine serum albumin 
(BSA) and 1 mM isobutylmethylxanthine 
(IBMX). PTH and PTHrP bind to the PTH/ 
PTHrP receptor on osteoblastic cells with simi- 
lar binding affinity and biologic activity [Jiipp- 
ner et al., 19881. The media was aspirated and 
750 p,1 ice-cold 5% perchloric acid was added to 
each well. The plates were incubated at -20°C 
overnight to extract the CAMP. After thawing, 
the extract was transferred to tubes, the pH was 
adjusted to 7.5 with 4N KOH, and the extract 
was centrifuged to remove the precipitate. The 
neutralized extract was then assayed for CAMP 
content using a CAMP binding protein assay. 
Parallel wells were analyzed for DNA content by 
fluorimetric analysis as described above. 
The CAMP binding protein assay was per- 
formed as follows. To each tube was added assay 
buffer (50 mM Tris, 5 mM EDTA, pH 7.41, 100 
p,1 standards or unknowns, [3Hl-cAMP (10,000 
cpm/tube), and CAMP binding protein sufficient 
to bind 40-60% of the radioactivity in a final 
volume of 250 p,l. The tubes were incubated for 
90 min on ice. Dextran-coated charcoal (0.5 
mg/ml dextran and 5.0 mg/ml charcoal) was 
added to each tube (600 p,l), incubated an addi- 
tional 30 min on ice, then centrifuged to remove 
the unbound from the bound CAMP-binding pro- 
tein-[3H]-cAMP complexes. The supernatant was 
decanted directly into scintillation vials and 
counted in a liquid scintillation spectrophotom- 
eter. Samples were run in duplicate and the 
concentration of CAMP was calculated by the 
log-logit method using Securia 1.0 (Packard In- 
struments, Indianapolis, IN). Data were ex- 
pressed as pmol cAMP/p,g DNA or as a ratio of 
T/C (PTH-stimulated vs. vehicle control). 
Statistical Analysis 
Data for the adenylate cyclase assays were 
evaluated using Instat 1.1 (GraphPAD Soft- 
ware, Inc., San Diego, CA) and an MS/DOS 
computer. Analysis of variance followed by mul- 
tiple comparisons using a Tukey’s mean separa- 
tion test were used to determine statistically 
significant (P  < 0.05) differences between 
groups. Nonlinear regression of the binding 
curve for PTHrP was performed with Prism@ 
(Graph Pad Software, San Diego, CA) using 
nonlinear curve fitting. Autoradiographs from 
the northern blot analysis were evaluated for 
relative signal density with NIH Image Soft- 
ware on a MacIntosh computer. 
RESULTS 
MC3T3-El cells were plated and allowed to 
attach overnight. The next day fresh media con- 
taining ascorbic acid and P-glycerophosphate was 
added. The first few days was a period of rapid 
proliferation. The cells reached confluence by 
day 3-4 but continued to proliferate as reflected 
by a 12-fold increase in cellular DNA through 
the culture period (Fig. 1). Since the primary 
calvarial osteoblasts were isolated directly from 
fetal calvaria subjected to collagenase digestion, 
a longer acclimation period was allowed prior to 
the addition of ascorbic acid and P-glycerophos- 
phate (2-3 day). The DNA levels at day 0 were 
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Fig. 1. Effects of differentiation on DNA levels in osteoblastic 
cells. Cells were plated at 10,000-20,000/cm2 and induced to 
differentiate with the addition of ascorbic acid (50 kg/ml). At 
the indicated time points, samples were collected and DNA 
values determined in triplicate by fluorometric analysis. The 
data are a representative plot from one of three experiments 
and are expressed as mean ? standard deviation of triplicate 
determinations. 
similar to  the MC3T3-El cells, however, slightly 
higher and increased 17-fold over the 26 day 
culture period. Steady state mRNA levels for the 
PTH/PTHrP receptor in MC3T3-El cells were 
initially low, and increased 4-fold to  peak levels 
at day 4 (Fig. 2). Subsequently, mRNA levels for 
the PTH/PTHrP receptor gradually declined 
through the culture period. The primary cal- 
varial cells followed a similar pattern with a 
3-fold increase in PTH/PTHrP receptor steady 
state mRNA reaching a peak at  day 5, and 
declining thereafter. 
To determine whether there was an alteration 
in the number of receptors or the binding f i n -  
ity of PTH/PTHrP receptors during differentia- 
tion, competition binding curves were per- 
formed at various time points during the culture 
period. Figure 3 contains binding curves for 
MC3T3-El cells during differentiation. There 
was specific binding of PTHrP to MC3T3-El 
cells at all time points during the culture period; 
however, initially the binding curve was rela- 
tively flat. Peak levels of cpm specifically bound 
to MC3T3-El cells occurred at day 7. Further 
increases in total binding were attributed to a 
concomitant increase in non-specific binding. 
The EC50 and number of receptors per kg DNA 
are listed in Table I, and account for the alter- 
ations in cell number during the culture period. 
For the early time periods the levels of binding 
t MC3T3-EI cells 
+ Primary calvarial cells 
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Fig. 2. PTH/PTHrP receptor mRNA expression during differen- 
tiation. A: Autoradiograph of northern blot analysis of PTH/ 
PTHrP receptor mRNA and 18s rRNA isolated from MC3T3-El 
cells during differentiation. B: Autoradiograph of northern blot 
analysis of PTH/PTHrP receptor mRNA and 18s rRNA isolated 
from primary calvarial cells during differentiation. Autoradio- 
graphs are a representative sample from three experiments. C: 
Plot of mean values of relative expression (PTH/PTHrP receptor 
vs. 18s rRNA expressed relative to the expression at time zero) 
from two separate experiments. 
were too low to obtain accurate EC50 and B, 
values. During the culture period the EC50 val- 
ues were similar, with the highest affinity 
reached at day 14; however, the number of recep- 
tors per cell was highest at day 3 and was lower 
at day 14. Similar results were found for the 
primary calvarial cells. The binding affinity was 
highest at day 12; however, the numbers of 
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Fig. 3. Competition binding curves for MC3T3-EI cells during 
differentiation. MC3T3-El cells were plated at 10,000/cm2 and 
induced to differentiate with the addition of ascorbic acid. 
Competition binding curves were performed using 20,000 cpm 
1251-PTHrP (1-36) and the indicated concentrations of non- 
iodinated PTHrP (1-34) from day 0-14. Data is expressed as 
mean 2 SEM for triplicate samples from one of three experi- 
ments with similar results. Derived values for EC50 and number 
of binding sites are in Table I .  
TABLE I. Binding Analysis of 
MC3T3-El Cells* 
Day EC50 # Receptorsiyg DNA 
0 
3 6.35 e-10 
7 3.64 e-10 
9 3.34 e-10 
12 3.17 e-10 







*Calculated using nonlinear regression and Scatchard analy- 
sis o f  data f rom competition binding curves depicted in 
Figure 3. 
receptors was greatest at day 5 (Fig. 4 and Table 
11). 
In order to correlate biologic activity with the 
presence of the PTHiPTHrP receptor, an evalu- 
ation of PTHrP-stimulated CAMP levels during 
differentiation was performed. The data re- 
ported in Figure 5, is expressed as a ratio of T 
(PTHrP stimulated samples) vs. C (non-stimu- 
lated) since there were slight increases in basal 
CAMP levels during the culture period. The mean 
basal CAMP levels ranged from 0.99 to 2.49, and 
0.46 t o  5.65 pmol/pg DNA for the MC3T3-El 
and primary calvarial cells respectively. The 
PTHrP-stimulated CAMP values ranged from 
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Fig. 4. Competition binding curves for primary calvarial cells 
during differentiation. Primary calvarial cells were isolated and 
plated at 20,000/cm2 and induced to  differentiate with the 
addition of ascorbic acid. Competition binding curves were 
performed using 20,000 cpm 1251-PTHrP (1-36) and the indi- 
cated concentrations of non-iodinated PTHrP (1-34) from day 
0-12. Data is expressed as mean 2 SEM for triplicate samples 
from one of two experiments with similar results. Derived 
values for EC50 and number of binding sites are in Table 11.  
TABLE 11. Binding Analysis of Primary 
Calvarial Cells* 
# Receptorsiyg DNA Day EC50 
0 
3 6.18 e-10 
5 8.93 e-10 
7 4.72 e-10 






*Calculated using nonlinear regression and Scatchard analy- 
sis o f  data f rom competition binding curves depicted in 
Figure 4. 
DNA for the MC3T3-El and primary calvarial 
cells respectively. The PTHrP-stimulated CAMP 
levels in MC3T3-El cells were initially low and 
increased 5-fold to peak values at day 5 and 
decreased thereafter. The PTHrP-stimulated 
CAMP levels in the primary calvarial osteoblasts 
were also low initially and increased 6-fold with 
a peak at day 4 and subsequently decreased to 
below initial values from day 17-26. 
The studies reported in Figures 6-8 evaluated 
the requirements for ascorbic acid and collagen 
matrix synthesis in receptor expression. Experi- 
ments used the strategy and experimental condi- 
tions recently employed to demonstrate that 
ascorbic acid and collagen synthesis are neces- 
sary for the induction of alkaline phosphatase 
and osteocalcin in MC3T3-El cells [Franceschi 
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Fig. 5. Effects of differentiation on PTHrP-stimulated cAMP 
levels in osteoblastic cells. Cells were plated at 10,000-20,000i 
cm2 and induced to differentiate with ascorbic acid (50 pg/ml). 
At the indicated time periods, samples were either stimulated 
with PTHrP (1-34) (10 nM) or vehicle control for 10 min. The 
cAMP levels are expressed as the ratio of PTHrP-stimulated/ 
control (mean ? SEM for triplicate samples from one of two 
experiments with similar results). 
and Iyer, 1992; Franceschi et al., 19941. In the 
experiment in Figure 6, cells were grown for 3 
days in control and ascorbic acid-containing me- 
dium before CAMP production in the presence 
and absence of PTH was measured. Ascorbic 
acid did not affect basal CAMP levels, but doubled 
PTH-dependent CAMP production. Figure 7 in- 
dicates that collagen synthesis is also required 
for the expression of the PTH/PTHrP receptor. 
Control and ascorbic acid-treated MC3T3-E 1 
cells were grown in the presence or absence of 
3,4-dehydroproline (3,4-DHP), a specific inhibi- 
tor of triple-helical collagen formation. Ascorbic 
acid increased receptor mRNA 4-fold after 6 
days and this stimulation persisted to day 8 and 
10. In contrast, if 3,4-DHP was added with 
ascorbic acid at  the start of the experiment, no 
stimulation of the PTH/PTHrP message was 
detected. However, if cells were pretreated with 
ascorbic acid for 6 days before inhibitor addi- 
tion, no block in mRNA induction was seen after 
2 or 4 additional days. Similar results were 
found for the effects of ascorbic acid and 3,4- 
DHP on 1251-PTHrP binding to PTH/PTHrP 
receptors in MC3T3-El cells (Fig. 8). Competi- 
tion binding curves indicate that the EC50 val- 
ues were not altered for the indicated treatment 
conditions. However, the numbers of receptors 
Fig. 6. Stimulation of PTH-dependent CAMP production by 
ascorbic acid. MC3T3-EI cells were cultured in control or 
ascorbic acid-containing medium for 3 days followed by mea- 
surement of basal (open bars) or PTH (1-34)-stimulated (10 
min) (hatched bars) cAMP levels. Values are expressed as 
mean * SEM for pmol cAMP normalized to cell DNA. 
were higher for the ascorbic acid-treated cells, 
and inhibition of collagen synthesis with 3,4- 
DHP resulted in a reduction in receptor num- 
bers to control values. Our previous work estab- 
lished that the concentration of 3,4-DHP used 
in this experiment (500 p,M) blocks greater than 
95% of total type I collagen synthesis [France- 
schi et al., 19941. Actions of this inhibitor are 
fully reversible and not associated with cellular 
toxicity. This was further substantiated since 
there was no significant difference in the DNA 
levels for the DHP treatment groups depicted in 
Figure 8 (data not shown). 
DISCUSSION 
The process of osteoblast differentiation has 
been characterized with a stepwise sequence of 
expression for phenotypic mineral-associated 
proteins [Lian and Stein, 19921. Other studies 
have described the sequence of gene expression 
for osteocalcin, osteopontin, H4 histone, bone 
sialoprotein, c-fos, type I collagen, and alkaline 
phosphatase and related these phenotypic char- 
acteristics with matrix synthesis and the accu- 
mulation of calcium and phosphate in mineral- 
ized nodules [Kockx et al., 1994; Machwate et 
al., 1995; Ibaraki et al., 1992; Franceschi and 
Iyer, 19921. Studies of this type provide valuable 
644 McCauley et  al. 
6CD L 
Control-DHP I- -------- -- I 
6A 8A 10A 
Ascorbic Acid _i-"-" 
6A+ 6A+ 
2AD 4AD 
"T -7  
6AD 
i 
Ascorbic Acid-DHP + - - - - - - - - - - 4 
Fig. 7. Requirement of ascorbic acid and collagen matrix 
synthesis for expression of PTH/PTHrP receptor mRNA. A: 
Experimental outline: MC3T3-El cells were grown for 6 days in 
control medium (6C),  control medium containing 500 FM 
3,4-DHP (6CD),  medium containing 50 pg/mL ascorbic acid 
(6A) or ascorbic acid-containing medium plus 3,4-DHP (6AD). 
Some control cultures were grown for an additional 2 (8C)  or 4 
(70C) days. At day 6, ascorbic acid-treated cells were divided 
information which has contributed to the under- 
standing of osteoblast function. The present 
study determined the temporal pattern of gene 
expression, protein binding, and biologic activity 
for the PTH/PTHrP receptor in two calvarial 
osteoblastic cell systems. The MC3T3-E 1 cells 
are a well-characterized immortalized osteoblas- 
tic cell line which undergo a specified pattern of 
differentiation in vitro [Franceschi and Iyer, 19921. 
Primary rat calvarial cells were also utilized since 
these cells are used extensively in mineralized tis- 
sue research as a model of differentiation. 
The results of the present study indicate that 
the PTHiPTHrP receptor is initially expressed 
in low to undetectable levels in both culture 
into the following groups: continued ascorbic acid treatment 
(SA, 70A), ascorbic acid plus 3,4DHP for two (6A + 2AD) or 
four days (6A + 4AD). For each group, total RNA was isolated 
and northern blot hybridization performed. B: Representative 
autoradiograph of northern blot analysis for PTH/PTHrP recep- 
tor mRNA from two experiments, (C) Scanning densitometry of 
northern blot from (B) normalized to rRNA. 
systems, and requires several days of differentia- 
tion induced by ascorbic acid for maximal expres- 
sion. This is an important finding since many 
studies in the past have used the presence of a 
PTH/PTHrP receptor as an indication that a 
cell is of the osteoblast lineage. The data pre- 
sented in this investigation indicate that the 
time period of PTH/PTHrP receptor expression 
is dependent temporally on the differentiation 
state of the cell. Consequently, an immature 
osteoblastic cell or an inactive osteoblastic cell 
should not be discarded as being of the osteo- 
blast lineage if it is not actively responding to 
PTH; however, a PTH-response may reflect the 
differentiation state of the osteoblast. 
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Fig. 8. Requirement of ascorbic acid and collagen matrix 
synthesis for PTH/PTHrP receptor binding. MC3T3-El cells 
were plated at 50,000/cm2 and cultured for 6 days in control 
medium, control medium containing 500 pM 3,4-DHP, me- 
dium containing 50 pg/mL ascorbic acid, or ascorbic acid- 
containing medium plus 3,4-DHP. A: Competition binding 
These results are in agreement with in situ 
hybridization studies performed by Lee et al. 
[19941. They reported the detection of mRNA 
signal for the PTH/PTHrP receptor over cuboi- 
dal cells lining the trabeculae in rat femur. These 
cells appeared to be active osteoblasts as deter- 




curves were performed using 20,000 cpm 12%PTHrP (1-36) 
and the indicated concentrations of non-iodinated PTHrP (1- 
34). Data is expressed mean ? SEM for triplicate samples from 
one of two experiments with similar results. B: Scatchard 
analysis was utilized to determine the numbers of receptors per 
pg DNAfor the experiment depicted in (A). 
tectable signal was found over bone marrow 
stromal cells or osteocytes which may represent 
precursor and mature forms of cells of the osteo- 
blast lineage respectively. A previous study, how- 
ever, did not find the highest levels of PTH 
receptors over osteoblastic cells. Rouleau et al. 
performed an in vivo autoradiography study to  
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identify cells which bound lZ51-PTH-( 1-34) [Rou- 
leau et al., 19883. They reported the presence of 
competitive binding to mature osteoblasts; how- 
ever, the greatest binding was over large mono- 
nuclear cells in the intratrabecular space of the 
metaphyseal region of rat long bones. There was 
no definitive identification of this cell other than 
it had a large flattened cell body with numerous 
cytoplasmic extensions. Since the present study 
was performed with calvarial osteoblastic cells 
in vitro, cells of the lineage that Rouleau de- 
scribed were likely not present. 
A study by Heath et al. [19891 described the 
isolation and immortalization of two rat cal- 
varial cell lines, RCT-1 and RCT-3. The RCT-1 
cells were described as immature and displayed 
a PTH-stimulated CAMP response only after 3 
days of retinoic acid induced differentiation. The 
RCT-3 cells were described as active osteoblasts 
and constitutively displayed a PTH-stimulated 
CAMP. These findings support the concept that 
immature osteoblastic cells are dependent on 
differentiation for the expression and function 
of the PTHiPTHrP receptor. 
In the present study, the highest numbers of 
receptors correlated with the maximal CAMP 
response. The small apparent variation in EC50 
values for ligand binding (2-3-fold) are probably 
not significant. Instead, CAMP levels correlated 
with receptor number and not binding affinity. 
The peak values of PTH/PTHrP receptor bind- 
ing and biologic activity also coincided with the 
time period in which active matrix synthesis is 
initiated. This indicates that the synthesis of 
matrix surrounding the osteoblasts may regu- 
late expression and activity of the PTH/PTHrP 
receptor as has been reported for other osteo- 
blast markers [Franceschi and Iyer, 1992; Fran- 
ceschi et al., 19941. Consistent with this possibil- 
ity, ascorbic acid strongly stimulated PTH/ 
PTHrP receptor mRNA levels and PTH- 
dependent CAMP production. Furthermore, the 
ascorbic acid-dependent induction of receptor 
mRNA and lZ51-PTHrP binding activity was com- 
pletely blocked by a specific inhibitor of collagen 
matrix synthesis, 3,4-dehydroproline. This pro- 
line analog is incorporated into type I procolla- 
gen where it inhibits hydroxylation, triple helix 
formation, and subsequent extracellular matrix 
deposition [Vitto and Prockop, 19751. If inhibi- 
tor addition was delayed until cells had already 
begun to form a collagenous matrix (day 6), 
further suppression of matrix production no 
longer interfered with receptor mRNA expres- 
sion. This result is similar to our previous find- 
ings with alkaline phosphatase and osteocalcin 
and suggests that short periods of collagen ma- 
trix synthesis generate a stable inductive signal 
for osteoblast marker gene expression. This sig- 
nal may be generated by interactions between 
the extracellular matrix and cell surface recep- 
tors such as integrins or other components pres- 
ent in the matrix of ascorbic acid-treated cells. 
In summary, the data presented here indicate 
that the PTH/PTHrP receptor is associated tem- 
porally at the level of mRNA, protein and bio- 
logic activity with a differentiating, matrix- 
producing osteoblastic cell in vitro. 
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